Free Trial
→ [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (From Crypto Swap Profits) (Ad) Free CRBP Stock Alerts

Corbus Pharmaceuticals (CRBP) SEC Filings & 10K Form

Corbus Pharmaceuticals logo
$16.33 +0.25 (+1.55%)
(As of 11:01 AM ET)
Compare

Recent Corbus Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
11/14/2024
6:48 PM		Corbus Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
5:41 PM		Corbus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G
11/14/2024
2:09 PM		Corbus Pharmaceuticals (Subject)
Cormorant Asset Management, LP (Filed by)
Form SC 13G/A
11/12/2024
1:34 PM		Corbus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
8:37 AM		Adage Capital Management, L.P. (Filed by)
Corbus Pharmaceuticals (Subject)
Form SC 13G/A
11/07/2024
3:58 PM		Corbus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
7:41 AM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
10:28 AM		Corbus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
6:51 AM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM		BlackRock, Inc. (Filed by)
Corbus Pharmaceuticals (Subject)
Form SC 13G
10/15/2024
3:19 PM		Corbus Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
09/24/2024
3:04 PM		Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
3:44 PM		CATLIN AVERY W (Reporting)
Corbus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
3:52 PM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:45 PM		Corbus Pharmaceuticals (Issuer)
Kung Winston (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/20/2024
3:48 PM		Corbus Pharmaceuticals (Issuer)
Kung Winston (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
7:15 AM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:42 PM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
4:58 PM		Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
4:59 PM		Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
8:21 AM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
4:25 PM		Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:25 PM		Corbus Pharmaceuticals (Subject)
Moran Sean F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
3:30 PM		Corbus Pharmaceuticals (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:31 PM		CATLIN AVERY W (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:32 PM		Corbus Pharmaceuticals (Issuer)
Jenkins John Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
6:08 AM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
3:39 PM		Corbus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/20/2024
3:30 PM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:00 AM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:30 AM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
8:17 AM		Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:58 PM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
3:59 PM		Corbus Pharmaceuticals (Filer)
Form DEFA14A
03/22/2024
4:05 PM		Corbus Pharmaceuticals (Filer)
Form PRE 14A
03/20/2024
11:15 PM		Corbus Pharmaceuticals (Filer)
Form EFFECT
03/20/2024
4:07 PM		Corbus Pharmaceuticals (Filer)
Form 424B3
03/20/2024
4:10 PM		Corbus Pharmaceuticals (Filer)
Form 10-K/A
03/20/2024
4:13 PM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
3:52 PM		Corbus Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/12/2024
4:19 PM		Corbus Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address. 
03/12/2024
7:15 AM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
4:34 PM		Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:13 PM		Corbus Pharmaceuticals (Issuer)
Smethurst Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:07 PM		Corbus Pharmaceuticals (Issuer)
Smethurst Dominic (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/14/2024
3:45 PM		Corbus Pharmaceuticals (Subject)
K2 HealthVentures Equity Trust LLC (Filed by)
Form SC 13G/A
02/14/2024
2:19 PM		Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:26 PM		Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:47 PM		Corbus Pharmaceuticals (Subject)
Cormorant Global Healthcare Master Fund, LP (Filed by)
Form SC 13G
02/05/2024
7:12 AM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
7:55 PM		Corbus Pharmaceuticals (Filer)
Form 8-K/A
02/01/2024
4:27 PM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
4:09 PM		Corbus Pharmaceuticals (Filer)
Form 424B5
01/31/2024
8:16 AM		Corbus Pharmaceuticals (Filer)
Form S-3MEF
01/30/2024
7:40 PM		Corbus Pharmaceuticals (Filer)
Form 424B5
01/30/2024
7:41 PM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
5:07 PM		Corbus Pharmaceuticals (Issuer)
HOLMER ALAN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:56 PM		Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:18 PM		Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2024
3:23 PM		Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
3:40 PM		Corbus Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
01/29/2024
6:30 AM		Corbus Pharmaceuticals (Filer)
Form 424B3
01/29/2024
6:31 AM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
7:45 AM		Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CRBP) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners
The Crypto That’s Making Wall Street Sweat
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...
Crypto 101 Media | Sponsored
Missed Nvidia? Watch this ASAP
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time N...
Behind the Markets | Sponsored
Elon knows the truth, which is why they want him silenced
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...
Porter & Company | Sponsored